These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7086325)
21. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors. Ebenezer IS Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular and renal responses to chronic vasopressin infusion. Brown AJ; Lohmeier TE; Carroll RG; Meydrech EF Am J Physiol; 1986 Apr; 250(4 Pt 2):H584-94. PubMed ID: 3515969 [TBL] [Abstract][Full Text] [Related]
23. Enhanced monoaminergic neurotransmission by desglycinamide-arginine-vasopressin in human subjects. Jolkkonen J; Lehtinen M; Soininen H; Sennef C; Riekkinen P Neurosci Lett; 1987 May; 76(3):312-5. PubMed ID: 2438607 [TBL] [Abstract][Full Text] [Related]
24. Effects of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs. Johnson MD; Kinter LB; Beeuwkes R Am J Physiol; 1979 Jan; 236(1):F66-70. PubMed ID: 434155 [TBL] [Abstract][Full Text] [Related]
25. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898 [TBL] [Abstract][Full Text] [Related]
27. Interaction of changes in the third ventricular CSF tonicity, central and systemic AVP concentrations and water intake. Eriksson S; Simon-Oppermann C; Simon E; Gray DA Acta Physiol Scand; 1987 Aug; 130(4):575-83. PubMed ID: 3630735 [TBL] [Abstract][Full Text] [Related]
28. Vasopressin in blood and third ventricle CSF of dogs in chronic experiments. Simon-Oppermann C; Gray D; Szczepańska-Sadowska E; Simon E Am J Physiol; 1983 Oct; 245(4):R541-8. PubMed ID: 6624950 [TBL] [Abstract][Full Text] [Related]
29. The effect of AVP and DGAVP on the exploratory activity of rats. Skopková J; Lát J; Dvorská I; Hrbas P; Radil T Peptides; 1987; 8(5):785-90. PubMed ID: 3432126 [TBL] [Abstract][Full Text] [Related]
30. Diurnal pattern of plasma and cerebrospinal-fluid vasopressin levels in hydrocephalic patients: absence of a circadian rhythm and of a correlation between plasma and cerebrospinal-fluid variations. Barreca T; Franceschini R; Siani C; Messina V; Francaviglia N; Perria C; Rolandi E Horm Res; 1988; 30(1):28-31. PubMed ID: 3220462 [TBL] [Abstract][Full Text] [Related]
31. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Ermisch A; Barth T; Rühle HJ; Skopková J; Hrbas P; Landgraf R Endocrinol Exp; 1985 Mar; 19(1):29-37. PubMed ID: 3872788 [TBL] [Abstract][Full Text] [Related]
32. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs. Naitoh M; Suzuki H; Murakami M; Matsumoto A; Ichihara A; Nakamoto H; Yamamura Y; Saruta T Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468 [TBL] [Abstract][Full Text] [Related]
33. [Coagulo-fibrinolytic response to intranasal administration of low dose desmopressin acetate (DDAVP) in normal and hemophiliac subjects]. Kakishita E; Uomoto M; Nishida K; Hara M; Nagai K Rinsho Byori; 1982 Nov; 30(11):1230-4. PubMed ID: 7182595 [No Abstract] [Full Text] [Related]
34. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Mens WB; Witter A; van Wimersma Greidanus TB Brain Res; 1983 Feb; 262(1):143-9. PubMed ID: 6831225 [TBL] [Abstract][Full Text] [Related]
35. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors. Cheng SW; North WG Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339 [TBL] [Abstract][Full Text] [Related]
36. Changes in cerebrospinal fluid and plasma vasopressin in the febrile sheep. Kasting NW; Carr DB; Martin JB; Blume H; Bergland R Can J Physiol Pharmacol; 1983 Apr; 61(4):427-31. PubMed ID: 6861003 [TBL] [Abstract][Full Text] [Related]
37. Development of specific antisera against 9-desglycinamide-8-arginine vasopressin by site-specific immunization. van Bree JB; van Nispen JW; Verhoef JC; Breimer DD J Pharm Sci; 1991 Jan; 80(1):46-9. PubMed ID: 2013849 [TBL] [Abstract][Full Text] [Related]
38. Hyponatremia induced by vasopressin or desmopressin in female and male rats. Verbalis JG J Am Soc Nephrol; 1993 Mar; 3(9):1600-6. PubMed ID: 8507816 [TBL] [Abstract][Full Text] [Related]
39. Gradient of arginine vasopressin concentration but not angiotensin II concentration between cerebrospinal fluid of anterior 3rd ventricle and cisterna magna in dogs. Simon-Oppermann C; Eriksson S; Simon E; Gray DA Brain Res; 1987 Oct; 424(1):163-8. PubMed ID: 3690296 [TBL] [Abstract][Full Text] [Related]
40. Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone. Tilbrook AJ; Canny BJ; Stewart BJ; Serapiglia MD; Clarke IJ J Endocrinol; 1999 Aug; 162(2):301-11. PubMed ID: 10425469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]